Cosmos Pharmaceutical Corp. (3349) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cosmos Pharmaceutical Corp. (3349:JPX), powered by AI.

Current Price
¥6,150
P/E Ratio
15.7
Market Cap
487.4B
Sector
Healthcare
What is the Cosmos Pharmaceutical Corp. stock price forecast?

Cosmos Pharmaceutical Corp. is currently trading at ¥6,150. View real-time AI analysis on Alpha Lenz.

What is Cosmos Pharmaceutical Corp. insider trading activity?

View the latest insider trading data for Cosmos Pharmaceutical Corp. on Alpha Lenz.

What is Cosmos Pharmaceutical Corp.'s P/E ratio?

Cosmos Pharmaceutical Corp.'s P/E ratio is 15.7.

Cosmos Pharmaceutical Corp.

JPX · 3349
¥6,150+74(+1.22%)Market closedJPX regular session 09:00–15:00 JST
Ask about Cosmos Pharmaceutical Corp.'s future dividend policy...
Alpha Chat Insight

Cosmos Pharmaceutical Corp. trades at a P/E of 15.7 (fair value) with solid ROE of 12.7%. 3Y revenue CAGR of 10.2% highlights clear growth momentum.

Ask for details

Company Overview

Cosmos Pharmaceutical Corp. is a leading entity in the pharmaceutical retail sector, predominantly operating in Japan. The company's core purpose lies in the management and operation of drugstore chains, which provide a wide range of healthcare products and services to the public. In addition to its comprehensive selection of pharmaceuticals, Cosmos offers an array of consumer goods, including cosmetics, household items, and nutritional supplements. These product offerings cater to various consumer needs, enhancing the convenience and accessibility of essential goods. With a network of retail outlets strategically located across regions, Cosmos Pharmaceutical Corp. plays a significant role in fulfilling the everyday healthcare and lifestyle needs of consumers. The company’s business model emphasizes efficiency, customer satisfaction, and community engagement, contributing to its sustained market presence and influence in the competitive retail and healthcare sectors in Japan. Through these operations, Cosmos Pharmaceutical Corp. maintains its position as a pivotal player in the pharmaceutical and consumer retail market.

SectorHealthcare
IndustryPharmaceutical Retailers
Employees5,709

Company Statistics

FY 2025

Profile

¥487,424,400,000Market Cap
¥1,011,390,000,000Revenue
0.00Shares Out
5,709Employees

Margins

21.09%Gross
6.49%EBITDA
3.99%Operating
4.19%Pre-Tax
3.06%Net

Valuation

15.73P/E
1.89P/B
0.48EV/Sales
7.32EV/EBITDA
-567.43P/FCF

Growth (CAGR)

10.22%Rev 3Yr
8.12%Rev 5Yr
10.69%Op Inc 3Yr
6.79%Op Inc 5Yr
10.19%Net Inc 3Yr
7.64%Net Inc 5Yr

Returns

6.19%ROA
12.67%ROE
8.51%ROIC

Financial Health

¥57,038,000,000Cash & Cash Equivalents
¥210,254,000,000Net Debt
103.82%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Cosmos Pharmaceutical Corp. (ticker: 3349) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 5,709 employees. Market cap is $487.4B.

The current price is 6,150 with a P/E ratio of 15.73x and P/B of 1.89x.

ROE is 12.67% and operating margin is 3.99%. Annual revenue is $1.0T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Cosmos Pharmaceutical Corp. (3349) Stock Forecast 2026 ¥6,150 — Price, Financials & Analyst Targets | Alpha Lenz